Full Text of HB2380 102nd General Assembly
HB2380sam001 102ND GENERAL ASSEMBLY | Sen. Cristina Castro Filed: 4/6/2022
| | 10200HB2380sam001 | | LRB102 02861 CPF 38836 a |
|
| 1 | | AMENDMENT TO HOUSE BILL 2380
| 2 | | AMENDMENT NO. ______. Amend House Bill 2380 by replacing | 3 | | everything after the enacting clause with the following:
| 4 | | "Section 5. The Compassionate Use of Medical Cannabis | 5 | | Program Act is amended by changing Section 10 and by adding | 6 | | Section 103 as follows: | 7 | | (410 ILCS 130/10)
| 8 | | Sec. 10. Definitions. The following terms, as used in this | 9 | | Act, shall have the meanings set forth in this Section:
| 10 | | (a) "Adequate supply" means:
| 11 | | (1) 2.5 ounces of usable cannabis during a period of | 12 | | 14 days and that is derived solely from an intrastate | 13 | | source.
| 14 | | (2) Subject to the rules of the Department of Public | 15 | | Health, a patient may apply for a waiver where a | 16 | | certifying health care professional provides a substantial |
| | | 10200HB2380sam001 | - 2 - | LRB102 02861 CPF 38836 a |
|
| 1 | | medical basis in a signed, written statement asserting | 2 | | that, based on the patient's medical history, in the | 3 | | certifying health care professional's professional | 4 | | judgment, 2.5 ounces is an insufficient adequate supply | 5 | | for a 14-day period to properly alleviate the patient's | 6 | | debilitating medical condition or symptoms associated with | 7 | | the debilitating medical condition.
| 8 | | (3) This subsection may not be construed to authorize | 9 | | the possession of more than 2.5 ounces at any time without | 10 | | authority from the Department of Public Health.
| 11 | | (4) The pre-mixed weight of medical cannabis used in | 12 | | making a cannabis infused product shall apply toward the | 13 | | limit on the total amount of medical cannabis a registered | 14 | | qualifying patient may possess at any one time. | 15 | | (a-5) "Advanced practice registered nurse" means a person | 16 | | who is licensed under the Nurse Practice Act as an advanced | 17 | | practice registered nurse and has a controlled substances | 18 | | license under Article III of the Illinois Controlled | 19 | | Substances Act. | 20 | | (b) "Cannabis" has the meaning given that term in Section | 21 | | 3 of the Cannabis Control Act.
| 22 | | (c) "Cannabis plant monitoring system" means a system that | 23 | | includes, but is not limited to, testing and data collection | 24 | | established and maintained by the registered cultivation | 25 | | center and available to the Department for the purposes of | 26 | | documenting each cannabis plant and for monitoring plant |
| | | 10200HB2380sam001 | - 3 - | LRB102 02861 CPF 38836 a |
|
| 1 | | development throughout the life cycle of a cannabis plant | 2 | | cultivated for the intended use by a qualifying patient from | 3 | | seed planting to final packaging.
| 4 | | (d) "Cardholder" means a qualifying patient or a | 5 | | designated caregiver who has been issued and possesses a valid | 6 | | registry identification card by the Department of Public | 7 | | Health.
| 8 | | (d-5) "Certifying health care professional" means a | 9 | | physician, an advanced practice registered nurse, or a | 10 | | physician assistant. | 11 | | (e) "Cultivation center" means a facility operated by an | 12 | | organization or business that is registered by the Department | 13 | | of Agriculture to perform necessary activities to provide only | 14 | | registered medical cannabis dispensing organizations with | 15 | | usable medical cannabis.
| 16 | | (f) "Cultivation center agent" means a principal officer, | 17 | | board member, employee, or agent of a registered cultivation | 18 | | center who is 21 years of age or older and has not been | 19 | | convicted of an excluded offense.
| 20 | | (g) "Cultivation center agent identification card" means a | 21 | | document issued by the Department of Agriculture that | 22 | | identifies a person as a cultivation center agent.
| 23 | | (h) "Debilitating medical condition" means one or more of | 24 | | the following: | 25 | | (1) cancer, glaucoma, positive status for human | 26 | | immunodeficiency virus, acquired immune deficiency |
| | | 10200HB2380sam001 | - 4 - | LRB102 02861 CPF 38836 a |
|
| 1 | | syndrome, hepatitis C, amyotrophic lateral sclerosis, | 2 | | Crohn's disease (including, but not limited to, ulcerative | 3 | | colitis), agitation of Alzheimer's disease, | 4 | | cachexia/wasting syndrome, muscular dystrophy, severe | 5 | | fibromyalgia, spinal cord disease, including but not | 6 | | limited to arachnoiditis, Tarlov cysts, hydromyelia, | 7 | | syringomyelia, Rheumatoid arthritis, fibrous dysplasia, | 8 | | spinal cord injury, traumatic brain injury and | 9 | | post-concussion syndrome, Multiple Sclerosis, | 10 | | Arnold-Chiari malformation and Syringomyelia, | 11 | | Spinocerebellar Ataxia (SCA), Parkinson's, Tourette's, | 12 | | Myoclonus, Dystonia, Reflex Sympathetic Dystrophy, RSD | 13 | | (Complex Regional Pain Syndromes Type I), Causalgia, CRPS | 14 | | (Complex Regional Pain Syndromes Type II), | 15 | | Neurofibromatosis, Chronic Inflammatory Demyelinating | 16 | | Polyneuropathy, Sjogren's syndrome, Lupus, Interstitial | 17 | | Cystitis, Myasthenia Gravis, Hydrocephalus, nail-patella | 18 | | syndrome, residual limb pain, seizures (including those | 19 | | characteristic of epilepsy), post-traumatic stress | 20 | | disorder (PTSD), autism, chronic pain, irritable bowel | 21 | | syndrome, migraines, osteoarthritis, anorexia nervosa, | 22 | | Ehlers-Danlos Syndrome, Neuro-Behcet's Autoimmune | 23 | | Disease, neuropathy, polycystic kidney disease, superior | 24 | | canal dehiscence syndrome, or the treatment of these | 25 | | conditions;
| 26 | | (1.5) terminal illness with a diagnosis of 6 months or |
| | | 10200HB2380sam001 | - 5 - | LRB102 02861 CPF 38836 a |
|
| 1 | | less; if the terminal illness is not one of the qualifying | 2 | | debilitating medical conditions, then the certifying | 3 | | health care professional shall on the certification form | 4 | | identify the cause of the terminal illness; or | 5 | | (2) any other debilitating medical condition or its | 6 | | treatment that is added by the Department of Public Health | 7 | | by rule as provided in Section 45. | 8 | | (i) "Designated caregiver" means a person who: (1) is at | 9 | | least 21 years of age; (2) has agreed to assist with a | 10 | | patient's medical use of cannabis; (3) has not been convicted | 11 | | of an excluded offense; and (4) assists no more than one | 12 | | registered qualifying patient with his or her medical use of | 13 | | cannabis.
| 14 | | (j) "Dispensing organization agent identification card" | 15 | | means a document issued by the Department of Financial and | 16 | | Professional Regulation that identifies a person as a medical | 17 | | cannabis dispensing organization agent , as that term is | 18 | | defined under Section 1-10 of the Cannabis Regulation and Tax | 19 | | Act .
| 20 | | (k) "Enclosed, locked facility" means a room, greenhouse, | 21 | | building, or other enclosed area equipped with locks or other | 22 | | security devices that permit access only by a cultivation | 23 | | center's agents or a dispensing organization's agent working | 24 | | for the registered cultivation center or the registered | 25 | | dispensing organization to cultivate, store, and distribute | 26 | | cannabis for registered qualifying patients.
|
| | | 10200HB2380sam001 | - 6 - | LRB102 02861 CPF 38836 a |
|
| 1 | | (l) "Excluded offense" for cultivation center agents and | 2 | | dispensing organizations means:
| 3 | | (1) a violent crime defined in Section 3 of the Rights | 4 | | of Crime Victims and Witnesses Act or a substantially | 5 | | similar offense that was classified as a felony in the | 6 | | jurisdiction where the person was convicted; or
| 7 | | (2) a violation of a state or federal controlled | 8 | | substance law, the Cannabis Control Act, or the | 9 | | Methamphetamine Control and Community Protection Act that | 10 | | was classified as a felony in the jurisdiction where the | 11 | | person was convicted, except that the registering | 12 | | Department may waive this restriction if the person | 13 | | demonstrates to the registering Department's satisfaction | 14 | | that his or her conviction was for the possession, | 15 | | cultivation, transfer, or delivery of a reasonable amount | 16 | | of cannabis intended for medical use. This exception does | 17 | | not apply if the conviction was under state law and | 18 | | involved a violation of an existing medical cannabis law.
| 19 | | For purposes of this subsection, the Department of Public | 20 | | Health shall determine by emergency rule within 30 days after | 21 | | the effective date of this amendatory Act of the 99th General | 22 | | Assembly what constitutes a "reasonable amount". | 23 | | (l-5) (Blank). | 24 | | (l-10) "Illinois Cannabis Tracking System" means a | 25 | | web-based system established and maintained by the Department | 26 | | of Public Health that is available to the Department of |
| | | 10200HB2380sam001 | - 7 - | LRB102 02861 CPF 38836 a |
|
| 1 | | Agriculture, the Department of Financial and Professional | 2 | | Regulation, the Illinois State Police, and registered medical | 3 | | cannabis dispensing organizations on a 24-hour basis to upload | 4 | | written certifications for Opioid Alternative Pilot Program | 5 | | participants, to verify Opioid Alternative Pilot Program | 6 | | participants, to verify Opioid Alternative Pilot Program | 7 | | participants' available cannabis allotment and assigned | 8 | | dispensary, and the tracking of the date of sale, amount, and | 9 | | price of medical cannabis purchased by an Opioid Alternative | 10 | | Pilot Program participant. | 11 | | (m) "Medical cannabis cultivation center registration" | 12 | | means a registration issued by the Department of Agriculture. | 13 | | (n) "Medical cannabis container" means a sealed, | 14 | | traceable, food compliant, tamper resistant, tamper evident | 15 | | container, or package used for the purpose of containment of | 16 | | medical cannabis from a cultivation center to a dispensing | 17 | | organization.
| 18 | | (o) "Medical cannabis dispensing organization", or | 19 | | "dispensing organization", or "dispensary organization" means | 20 | | a facility operated by an organization or business that is | 21 | | registered by the Department of Financial and Professional | 22 | | Regulation to acquire medical cannabis from a registered | 23 | | cultivation center for the purpose of dispensing cannabis, | 24 | | paraphernalia, or related supplies and educational materials | 25 | | to registered qualifying patients, individuals with a | 26 | | provisional registration for qualifying patient cardholder |
| | | 10200HB2380sam001 | - 8 - | LRB102 02861 CPF 38836 a |
|
| 1 | | status, or an Opioid Alternative Pilot Program participant.
| 2 | | (p) "Medical cannabis dispensing organization agent" or | 3 | | "dispensing organization agent" means a principal officer, | 4 | | board member, employee, or agent of a registered medical | 5 | | cannabis dispensing organization who is 21 years of age or | 6 | | older and has not been convicted of an excluded offense.
| 7 | | (q) "Medical cannabis infused product" means food, oils, | 8 | | ointments, or other products containing usable cannabis that | 9 | | are not smoked.
| 10 | | (r) "Medical use" means the acquisition; administration; | 11 | | delivery; possession; transfer; transportation; or use of | 12 | | cannabis to treat or alleviate a registered qualifying | 13 | | patient's debilitating medical condition or symptoms | 14 | | associated with the patient's debilitating medical condition.
| 15 | | (r-5) "Opioid" means a narcotic drug or substance that is | 16 | | a
Schedule II controlled substance under paragraph (1), (2), | 17 | | (3),
or (5) of subsection (b) or under subsection (c) of | 18 | | Section 206
of the Illinois Controlled Substances Act. | 19 | | (r-10) "Opioid Alternative Pilot Program participant" | 20 | | means an individual who has
received a valid written | 21 | | certification to participate in the Opioid Alternative Pilot | 22 | | Program for a medical condition for
which an opioid has been or | 23 | | could be prescribed by a certifying health care professional
| 24 | | based on generally accepted standards of care. | 25 | | (s) "Physician" means a doctor of medicine or doctor of | 26 | | osteopathy licensed under the Medical Practice Act of 1987 to |
| | | 10200HB2380sam001 | - 9 - | LRB102 02861 CPF 38836 a |
|
| 1 | | practice medicine and who has a controlled substances license | 2 | | under Article III of the Illinois Controlled Substances Act. | 3 | | It does not include a licensed practitioner under any other | 4 | | Act including but not limited to the Illinois Dental Practice | 5 | | Act.
| 6 | | (s-1) "Physician assistant" means a physician assistant | 7 | | licensed under the Physician Assistant Practice Act of 1987 | 8 | | and who has a controlled substances license under Article III | 9 | | of the Illinois Controlled Substances Act. | 10 | | (s-5) "Provisional registration" means a document issued | 11 | | by the Department of Public Health to a qualifying patient who | 12 | | has submitted: (1) an online application and paid a fee to | 13 | | participate in Compassionate Use of Medical Cannabis Program | 14 | | pending approval or denial of the patient's application; or | 15 | | (2) a completed application for terminal illness. | 16 | | (t) "Qualifying patient" means a person who has been | 17 | | diagnosed by a certifying health care professional as having a | 18 | | debilitating medical condition.
| 19 | | (u) "Registered" means licensed, permitted, or otherwise | 20 | | certified by the Department of Agriculture, Department of | 21 | | Public Health, or Department of Financial and Professional | 22 | | Regulation.
| 23 | | (v) "Registry identification card" means a document issued | 24 | | by the Department of Public Health that identifies a person as | 25 | | a registered qualifying patient or registered designated | 26 | | caregiver.
|
| | | 10200HB2380sam001 | - 10 - | LRB102 02861 CPF 38836 a |
|
| 1 | | (w) "Usable cannabis" means the seeds, leaves, buds, and | 2 | | flowers of the cannabis plant and any mixture or preparation | 3 | | thereof, but does not include the stalks, and roots of the | 4 | | plant. It does not include the weight of any non-cannabis | 5 | | ingredients combined with cannabis, such as ingredients added | 6 | | to prepare a topical administration, food, or drink.
| 7 | | (x) "Verification system" means a Web-based system | 8 | | established and maintained by the Department of Public Health | 9 | | that is available to the Department of Agriculture, the | 10 | | Department of Financial and Professional Regulation, law | 11 | | enforcement personnel, and registered medical cannabis | 12 | | dispensing organization agents on a 24-hour basis for the | 13 | | verification of registry
identification cards, the tracking of | 14 | | delivery of medical cannabis to medical cannabis dispensing | 15 | | organizations, and the tracking of the date of sale, amount, | 16 | | and price of medical cannabis purchased by a registered | 17 | | qualifying patient.
| 18 | | (y) "Written certification" means a document dated and | 19 | | signed by a certifying health care professional, stating (1) | 20 | | that the qualifying patient has a debilitating medical | 21 | | condition and specifying the debilitating medical condition | 22 | | the qualifying patient has; and (2) that (A) the certifying | 23 | | health care professional is treating or managing treatment of | 24 | | the patient's debilitating medical condition; or (B) an Opioid | 25 | | Alternative Pilot Program participant has a medical condition | 26 | | for which opioids have been or could be prescribed. A written |
| | | 10200HB2380sam001 | - 11 - | LRB102 02861 CPF 38836 a |
|
| 1 | | certification shall be made only in the course of a bona fide | 2 | | health care professional-patient relationship, after the | 3 | | certifying health care professional has completed an | 4 | | assessment of either a qualifying patient's medical history or | 5 | | Opioid Alternative Pilot Program participant, reviewed | 6 | | relevant records related to the patient's debilitating | 7 | | condition, and conducted a physical examination. | 8 | | (z) "Bona fide health care professional-patient | 9 | | relationship" means a
relationship established at a hospital, | 10 | | certifying health care professional's office, or other health | 11 | | care facility in which the certifying health care professional | 12 | | has an ongoing responsibility for the assessment, care, and | 13 | | treatment of a
patient's debilitating medical condition or a | 14 | | symptom of the
patient's debilitating medical condition. | 15 | | A veteran who has received treatment at a VA hospital | 16 | | shall be deemed to have a bona fide health care | 17 | | professional-patient relationship with a VA certifying health | 18 | | care professional if the patient has been seen for his or her | 19 | | debilitating medical condition at the VA Hospital in | 20 | | accordance with VA Hospital protocols. | 21 | | A bona fide health care professional-patient relationship | 22 | | under this subsection is a privileged communication within the | 23 | | meaning of Section 8-802 of the Code of Civil Procedure.
| 24 | | (Source: P.A. 100-1114, eff. 8-28-18; 101-363, eff. 8-9-19.) | 25 | | (410 ILCS 130/103 new) |
| | | 10200HB2380sam001 | - 12 - | LRB102 02861 CPF 38836 a |
|
| 1 | | Sec. 103. Cultivation center agent identification cards. | 2 | | The Department of Agriculture shall follow the requirements | 3 | | set forth in Section 20-35 of the Cannabis Regulation and Tax | 4 | | Act regarding the administration of cultivation center agent | 5 | | identification cards under this Act. | 6 | | Section 10. The Cannabis Regulation and Tax Act is amended | 7 | | by adding Section 5-22 and by changing Section 15-40 as | 8 | | follows: | 9 | | (410 ILCS 705/5-22 new) | 10 | | Sec. 5-22. Identification cards. The Department of | 11 | | Agriculture and the Department of Financial and Professional | 12 | | Regulation shall issue all identification cards under this Act | 13 | | via an online application portal. | 14 | | (410 ILCS 705/15-40)
| 15 | | Sec. 15-40. Dispensing organization agent identification | 16 | | card; agent training. | 17 | | (a) The Department shall: | 18 | | (1) verify the information contained in an application | 19 | | or renewal for a dispensing organization agent | 20 | | identification card submitted under this Article, and | 21 | | approve or deny an application or renewal, within 30 days | 22 | | of receiving a completed application or renewal | 23 | | application and all supporting documentation required by |
| | | 10200HB2380sam001 | - 13 - | LRB102 02861 CPF 38836 a |
|
| 1 | | rule; | 2 | | (2) issue a dispensing organization agent | 3 | | identification card to a qualifying agent within 15 | 4 | | business days of approving the application or renewal; | 5 | | (3) enter the registry identification number of the | 6 | | dispensing organization where the agent works; | 7 | | (4) within one year from the effective date of this | 8 | | Act, allow for an electronic application process and | 9 | | provide a confirmation by electronic or other methods that | 10 | | an application has been submitted; and | 11 | | (5) collect a $100 nonrefundable fee from the | 12 | | applicant to be deposited into the Cannabis Regulation | 13 | | Fund. | 14 | | (b) A dispensing organization agent must keep his or her | 15 | | identification card visible at all times when in the | 16 | | dispensary. | 17 | | (c) The dispensing organization agent identification cards | 18 | | shall contain the following: | 19 | | (1) the name of the cardholder; | 20 | | (2) the date of issuance and expiration date of the | 21 | | dispensing organization agent identification cards; | 22 | | (3) a random 10-digit alphanumeric identification | 23 | | number containing at least 4 numbers and at least 4 | 24 | | letters that is unique to the cardholder; and | 25 | | (4) a photograph of the cardholder. | 26 | | (d) The dispensing organization agent identification cards |
| | | 10200HB2380sam001 | - 14 - | LRB102 02861 CPF 38836 a |
|
| 1 | | shall be immediately returned to the dispensing organization | 2 | | upon termination of employment. | 3 | | (e) The Department shall not issue an agent identification | 4 | | card if the applicant is delinquent in filing any required tax | 5 | | returns or paying any amounts owed to the State of Illinois. | 6 | | (f) Any card lost by a dispensing organization agent shall | 7 | | be reported to the Illinois State Police and the Department | 8 | | immediately upon discovery of the loss. | 9 | | (g) An applicant shall be denied a dispensing organization | 10 | | agent identification card renewal if he or she fails to | 11 | | complete the training provided for in this Section. | 12 | | (h) A dispensing organization agent shall only be required | 13 | | to hold one card for the same employer regardless of what type | 14 | | of dispensing organization license the employer holds. | 15 | | (i) Cannabis retail sales training requirements. | 16 | | (1) Within 90 days of September 1, 2019, or 90 days of | 17 | | employment, whichever is later, all owners, managers, | 18 | | employees, and agents involved in the handling or sale of | 19 | | cannabis or cannabis-infused product employed by an adult | 20 | | use dispensing organization or medical cannabis dispensing | 21 | | organization as defined in Section 10 of the Compassionate | 22 | | Use of Medical Cannabis Program Act shall attend and | 23 | | successfully complete a Responsible Vendor Program. | 24 | | (2) Each owner, manager, employee, and agent of an | 25 | | adult use dispensing organization or medical cannabis | 26 | | dispensing organization shall successfully complete the |
| | | 10200HB2380sam001 | - 15 - | LRB102 02861 CPF 38836 a |
|
| 1 | | program annually. | 2 | | (3) Responsible Vendor Program Training modules shall | 3 | | include at least 2 hours of instruction time approved by | 4 | | the Department including: | 5 | | (i) Health and safety concerns of cannabis use, | 6 | | including the responsible use of cannabis, its | 7 | | physical effects, onset of physiological effects, | 8 | | recognizing signs of impairment, and appropriate | 9 | | responses in the event of overconsumption. | 10 | | (ii) Training on laws and regulations on driving | 11 | | while under the influence and operating a watercraft | 12 | | or snowmobile while under the influence. | 13 | | (iii) Sales to minors prohibition. Training shall | 14 | | cover all relevant Illinois laws and rules. | 15 | | (iv) Quantity limitations on sales to purchasers. | 16 | | Training shall cover all relevant Illinois laws and | 17 | | rules. | 18 | | (v) Acceptable forms of identification. Training | 19 | | shall include: | 20 | | (I) How to check identification; and | 21 | | (II) Common mistakes made in verification; | 22 | | (vi) Safe storage of cannabis; | 23 | | (vii) Compliance with all inventory tracking | 24 | | system regulations; | 25 | | (viii) Waste handling, management, and disposal; | 26 | | (ix) Health and safety standards; |
| | | 10200HB2380sam001 | - 16 - | LRB102 02861 CPF 38836 a |
|
| 1 | | (x) Maintenance of records; | 2 | | (xi) Security and surveillance requirements; | 3 | | (xii) Permitting inspections by State and local | 4 | | licensing and enforcement authorities; | 5 | | (xiii) Privacy issues; | 6 | | (xiv) Packaging and labeling requirement for sales | 7 | | to purchasers; and | 8 | | (xv) Other areas as determined by rule. | 9 | | (j) Blank. | 10 | | (k) Upon the successful completion of the Responsible | 11 | | Vendor Program, the provider shall deliver proof of completion | 12 | | either through mail or electronic communication to the | 13 | | dispensing organization, which shall retain a copy of the | 14 | | certificate. | 15 | | (l) The license of a dispensing organization or medical | 16 | | cannabis dispensing organization whose owners, managers, | 17 | | employees, or agents fail to comply with this Section may be | 18 | | suspended or permanently revoked under Section 15-145 or may | 19 | | face other disciplinary action. | 20 | | (m) The regulation of dispensing organization and medical | 21 | | cannabis dispensing employer and employee training is an | 22 | | exclusive function of the State, and regulation by a unit of | 23 | | local government, including a home rule unit, is prohibited. | 24 | | This subsection (m) is a denial and limitation of home rule | 25 | | powers and functions under subsection (h) of Section 6 of | 26 | | Article VII of the Illinois Constitution. |
| | | 10200HB2380sam001 | - 17 - | LRB102 02861 CPF 38836 a |
|
| 1 | | (n) Persons seeking Department approval to offer the | 2 | | training required by paragraph (3) of subsection (i) may apply | 3 | | for such approval between August 1 and August 15 of each | 4 | | odd-numbered year in a manner prescribed by the Department. | 5 | | (o) Persons seeking Department approval to offer the | 6 | | training required by paragraph (3) of subsection (i) shall | 7 | | submit a nonrefundable application fee of $2,000 to be | 8 | | deposited into the Cannabis Regulation Fund or a fee as may be | 9 | | set by rule. Any changes made to the training module shall be | 10 | | approved by the Department.
| 11 | | (p) The Department shall not unreasonably deny approval of | 12 | | a training module that meets all the requirements of paragraph | 13 | | (3) of subsection (i). A denial of approval shall include a | 14 | | detailed description of the reasons for the denial. | 15 | | (q) Any person approved to provide the training required | 16 | | by paragraph (3) of subsection (i) shall submit an application | 17 | | for re-approval between August 1 and August 15 of each | 18 | | odd-numbered year and include a nonrefundable application fee | 19 | | of $2,000 to be deposited into the Cannabis Regulation Fund or | 20 | | a fee as may be set by rule.
| 21 | | (r) All persons applying to become or renewing their | 22 | | registrations to be agents, including agents-in-charge and | 23 | | principal officers, shall disclose any disciplinary action | 24 | | taken against them that may have occurred in Illinois, another | 25 | | state, or another country in relation to their employment at a | 26 | | cannabis business establishment or at any cannabis cultivation |
| | | 10200HB2380sam001 | - 18 - | LRB102 02861 CPF 38836 a |
|
| 1 | | center, processor, infuser, dispensary, or other cannabis | 2 | | business establishment. | 3 | | (s) An agent applicant may begin employment at a | 4 | | dispensing organization while the agent applicant's | 5 | | identification card application is pending. Upon approval, the | 6 | | Department shall issue the agent's identification card to the | 7 | | agent. If denied, the dispensing organization and the agent | 8 | | applicant shall be notified and the agent applicant must cease | 9 | | all activity at the dispensing organization immediately. | 10 | | (t) All notifications of acceptance or denial for | 11 | | applications under this Section shall be sent directly to the | 12 | | agent applicant. | 13 | | (Source: P.A. 101-27, eff. 6-25-19; 101-593, eff. 12-4-19; | 14 | | 102-98, eff. 7-15-21; 102-538, eff. 8-20-21; revised | 15 | | 10-12-21.) | 16 | | (410 ILCS 130/100 rep.) | 17 | | (410 ILCS 130/120 rep.) | 18 | | Section 20. The Compassionate Use of Medical Cannabis | 19 | | Program Act is amended by repealing Sections 100 and 120.".
|
|